Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
Portuguese (Brazilian)

Lay Summaries and Lay Summary Videos

  • SPIRIVA ® - Asthma
    Clinical Study Number 205.445
    Study Indication Asthma
    Product SPIRIVA ®
    Generic Name Tiotropium bromide
    Lab Code
    Clinical Phase III
    Study Title

    A randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution (2.5 mcg and 5 mcg) delivered via Respimat® inhaler once daily in the evening over 48 weeks in children (6 to 11 years old) with moderate persistent asthma

    Study Document
    Lay summary 205.445 english
    Lay summary 205.445 german
  • BI 443651 - Asthma
    Clinical Study Number 1363.7
    Study Indication Asthma
    Product BI 443651
    Generic Name BI 443651
    Lab Code BI 443651
    Clinical Phase I
    Study Title

    A 2-part phase I, multiple-dose, single- and double-blind randomised, doubledummy, placebo-controlled, 4-way crossover study to assess safety and tolerability of BI 443651 via Respimat® versus placebo via Respimat® in subjects with mild asthma following methacholine challenge

    Study Document
    Lay summary 1363.7 english